[1] 张志珊,严延生. 登革热实验诊断和疫苗的研究进展[J].中国人兽共患病学报, 2006, 22(5):460-463.
[2] World Health Organization.Dengue hemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed[R]. Geneva: WHO, 1997.
[3] Hemungkorn M, Thisyakorn U, Thisyakorn C.Dengue infection: a growing global health threat[J].Bioscience Trends, 2007,1(2): 90-96.
[4] 向浩,聂绍发. 登革热实验诊断技术进展[J].临床检验杂志,2006,4(2):156-157.
[5] 应若素,王建,洪文昕,等. 广东省2014年登革热暴发流行的临床和实验室特点[J]. 中华传染病杂志,2014,32(12):719-723.
[6] WHO. Global strategy for dengue prevention and control[R]. Geneva: WHO, 2012.
[7] WHO. Dengue fever and dengue hemorrhagic fever[R]. WHO Report No.117.2005.
[8] Simmons CP, Farrar JJ, vV N, et al. Dengue[J]. N Engl J Med, 2012, 366(15): 1423-1432.
[9] Luz PM, Vanni T, Medlock J, et al.Dengue vector control strategies in an urban setting: an economic modelling assessment[J]. Lancet, 2011, 377(9778): 1673-1680.
[10] Bhatt S, Gething PW, Brady OJ, et al.The global distribution and burden of dengue[J]. Nature, 2013, 496(7446): 504-507.
[11] 杜建伟,潘先海. 中国登革热流行概况与流行特征[J].中华流行病学杂, 2010, 31(12):1429-1433.
[12] 广东省卫生和计划生育委员会. 广东省登革热疫情通报[R]. 广州:2014.
[13] Balmaseda A, Hammond SN, Tdhz Y, et a1. High seroprevalence of antibodies against engue virus in a prospective study of schoolchildren in Managua, Nicaragua[J]. Trop Med Int ealth, 2006, 11(6): 935-942.
[14] Whitehead SS, Blaney JE, Durbin AP, et a1. Prospects for a dengue virus vaccine[J]. Nat Rev Microbiol, 2007, 5(7): 518-528.
[15] Rico-Hesse R.Molecular evolution and distribution of dengue viruses type 1 and 2 in Nature[J]. Virology, 1990, 174(2): 479-493.
[16] Normile D.Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts[J]. Science, 2013, 342(6157): 415.
[17] Mustafa M S, Rasotgi V, Jain S, et al.Discovery of fifth serotype of dengue virus(DENV-5): A new public health dilemma in dengue control[J]. Med J Armed Forces India, 2015, 71(1): 67-70.
[18] WHO/TDR. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New Edition. Geneva: World Health Organization, 2009.
[19] 张复春. 登革热的流行特点及治疗[J].医学与哲学(临床决策论坛版),2010,31(9):21-23.
[20] Fried JR, Gibbons RV, et al.Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006[J]. Plos Neglected Tropical Diseases, 2010, 4(3): 233-238.
[21] 周军,周芳等. 登革热的胸部CT表现[J]. 实用医学影像杂志, 2014,15(2):119-120.
[22] Rodrigues RS, Brum AL, Paes MV, et al.Lung in Dengue: Computed Tomography Findings[J]. Plos One, 2014, 9(5): 1-7.
[23] Ejaz K, Khursheed M.Pleural effusion in dengue[J].Saudi Med J, 2011, 32(1): 46-49.
[24] Pramuljo HS, Harun SR.Ultrasound findings in dengue hemorrhagic fever[J]. Pediatric Radiology, 1991, 21(2): 100-102.
[25] Balasubramanian S, Janakiraman L, et al.A reappraisal of the criteria to diagnose plasma leakage in dengue hemorrhagic fever[J]. Indian Pediatric, 2006, 43(4): 334-339.
[26] Srikiatkhachorn A, Krautrachue A, et al.Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study[J]. Pediatr Infect Dis J, 2007, 26(4): 283-290. |
